# Fulcrum Therapeutics, Inc.: Form 8-K, filed Aug 3, 2023

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2023-08-03
- Accepted by EDGAR: Aug 3, 2023, 07:05 ET
- Period: 2023-08-02
- Accession: 0000950170-23-037574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000095017023037574/fulc-20230802.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000095017023037574/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000095017023037574/fulc-20230802.htm

Filed Aug 3, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-037574. Last ingested by Listed: Nov 3, 2026, 08:45 ET. No prices; not investment advice.